((1aR,7aS,10aS,10bS,E)-1a-methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-5-yl)methyl 2-(5-fluoro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate

ID: ALA4565625

PubChem CID: 155554267

Max Phase: Preclinical

Molecular Formula: C22H25FN2O7

Molecular Weight: 448.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)Cn1cc(F)c(=O)n(C)c1=O)=C\CC[C@@]1(C)O[C@@H]21

Standard InChI:  InChI=1S/C22H25FN2O7/c1-12-14-7-6-13(5-4-8-22(2)18(32-22)17(14)31-20(12)28)11-30-16(26)10-25-9-15(23)19(27)24(3)21(25)29/h5,9,14,17-18H,1,4,6-8,10-11H2,2-3H3/b13-5+/t14-,17-,18-,22+/m0/s1

Standard InChI Key:  YEJQBBSIQYPYGQ-QVCRZLKCSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    4.4248  -20.3132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8762  -19.6320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0592  -19.5807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6845  -21.6297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3123  -21.1020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9888  -21.1956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1864  -20.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0004  -20.3407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1958  -19.5482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5054  -19.1133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4792  -18.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6831  -18.7579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8167  -17.7934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0186  -18.0056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2036  -17.9089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8933  -18.3472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6177  -17.9691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6525  -17.1526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3802  -20.0391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8050  -18.8143    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.1058  -21.2975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8109  -20.2712    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.7422  -22.4448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5036  -20.7723    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    8.3074  -18.4074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0319  -18.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7191  -18.4702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4412  -18.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4802  -17.2788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7908  -16.8384    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0623  -17.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3725  -16.7764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2061  -16.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1293  -18.5364    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.8283  -16.0220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  1  0
  5  8  1  0
  7  6  1  0
  6  4  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2  7  1  0
 10 11  1  0
  3 12  1  0
 11 13  2  0
 12 14  1  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
  3 19  1  1
  2 20  1  1
  5 21  2  0
  8 22  1  6
  4 23  2  0
  7 24  1  1
 17 25  1  0
 25 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 29 33  2  0
 28 34  1  0
 30 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4565625

    ---

Associated Targets(Human)

Bel7402/5-FU (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bel-7402 (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.45Molecular Weight (Monoisotopic): 448.1646AlogP: 0.98#Rotatable Bonds: 4
Polar Surface Area: 109.13Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.72CX LogD: 1.72
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.29Np Likeness Score: 1.50

References

1. Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q..  (2019)  Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.,  183  [PMID:31553932] [10.1016/j.ejmech.2019.111706]

Source